Publications

Found 125 results
[ Author(Asc)] Title Type Year
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
L
Leach LL, Buchholz DE, Nadar VP, Lowenstein SE, Clegg DO.  2015.  Canonical/β-catenin Wnt pathway activation improves retinal pigmented epithelium derivation from human embryonic stem cells. Investigative Ophthalmology & Visual Science. 56(2):1002-13.
Leach LL, Croze RH, Hu Q, Nadar VP, Clevenger TN, Pennington BO, Gamm DM, Clegg DO.  2016.  Induced Pluripotent Stem Cell-Derived Retinal Pigmented Epithelium: A Comparative Study Between Cell Lines and Differentiation Methods. J Ocul Pharmacol Ther. 32(5):317-30.
Large TH, Bodary SC, Clegg DO, Weskamp G, Otten U, Reichardt LF.  1986.  Nerve growth factor gene expression in the developing rat brain. Science. 234(4774):352-5.
K
Koss MJ, Falabella P, Stefanini FR, Pfister M, Thomas BB, Kashani AH, Brant R, Zhu D, Clegg DO, Hinton DR et al..  2016.  Subretinal implantation of a monolayer of human embryonic stem cell-derived retinal pigment epithelium: a feasibility and safety study in Yucatán minipigs. Graefes Arch Clin Exp Ophthalmol. 254(8):1553-65.
Kolhar P, Kotamraju VRamana, Hikita ST, Clegg DO, Ruoslahti E.  2010.  Synthetic surfaces for human embryonic stem cell culture. Journal of Biotechnology. 146(3):143-6.
Kil SH, Krull CE, Cann G, Clegg D, Bronner-Fraser M.  1998.  The alpha4 subunit of integrin is important for neural crest cell migration. Developmental Biology. 202(1):29-42.
Kashani AH, Lebkowski JS, Rahhal FM, Avery RL, Salehi-Had H, Dang W, Lin C-M, Mitra D, Zhu D, Thomas BB et al..  2018.  A bioengineered retinal pigment epithelial monolayer for advanced, dry age-related macular degeneration.. Science Translational Medicine. 10(435)
Kashani AH, Uang J, Mert M, Rahhal F, Chan C, Avery RL, Dugel P, Chen S, Lebkowski J, Clegg DO et al..  2020.  Surgical Method for Implantation of a Biosynthetic Retinal Pigment Epithelium Monolayer for Geographic Atrophy: Experience from a Phase 1/2a Study.. Ophthalmol Retina. 4(3):264-273.
Kashani AH, Lebkowski JS, Rahhal FM, Avery RL, Salehi-Had H, Chen S, Chan C, Palejwala N, Ingram A, Dang W et al..  2021.  One-Year Follow-Up in a Phase 1/2a Clinical Trial of an Allogeneic RPE Cell Bioengineered Implant for Advanced Dry Age-Related Macular Degeneration.. Transl Vis Sci Technol. 10(10):13.
Kashani AH, Lebkowski JS, Hinton DR, Zhu D, Faynus MA, Chen S, Rahhal FM, Avery RL, Salehi-Had H, Chan C et al..  2022.  Survival of an HLA-mismatched, bioengineered RPE implant in dry age-related macular degeneration.. Stem Cell Reports. 17(3):448-458.
H
Humayun M, Ahuja A, Tai Y-C, Hinton D, Grubbs R, Clegg D, JOHNSON LVallance, Hikita ST, .  2011.  Biocompatible substrate for facilitating interconnections between stem cells and target tissues and methods for implanting same.
Huang X, Hu Q, Braun GB, Pallaoro A, Morales DP, Zasadzinski J, Clegg DO, Reich NO.  2015.  Light-activated RNA interference in human embryonic stem cells. Biomaterials. 63:70-9.
Huang X, Hu Q, Lai Y, Morales DP, Clegg DO, Reich NO.  2016.  Light-Patterned RNA Interference of 3D-Cultured Human Embryonic Stem Cells. Adv Mater. 28(48):10732-10737.
Hu Q, Chen R, Teesalu T, Ruoslahti E, Clegg DO.  2014.  Reprogramming human retinal pigmented epithelial cells to neurons using recombinant proteins. Stem Cells Translational Medicine. 3(12):1526-34.
Hu Q, Friedrich AM, Johnson LV, Clegg DO.  2010.  Memory in induced pluripotent stem cells: reprogrammed human retinal-pigmented epithelial cells show tendency for spontaneous redifferentiation. Stem Cells. 28(11):1981-91.
Hu Y, Liu L, Lu B, Zhu D, Ribeiro R, Diniz B, Thomas PB, Ahuja AK, Hinton DR, Tai Y-C et al..  2012.  A novel approach for subretinal implantation of ultrathin substrates containing stem cell-derived retinal pigment epithelium monolayer. Ophthalmic Research. 48(4):186-91.
Hikita ST, Vistica BP, Watson MM, Gery I, Clegg DO.  2005.  Investigation of the Pro-Inflammatory Function of Osteopontin in Experimental Autoimmune Uveitis. Investigative Ophtalmology & Visual Science. 46:993.
Hikita ST, Vistica BP, Gery I, Clegg DO.  2004.  Investigation of the pro-inflammatory function of osteopontin in retinal autoimmune disease. Molecular Biology of the Cell. 15:302A–303A.
Hikita S, Clegg D, Johnson L, Miller L, Tsie M, Presbrey C, Conti L, Maloney M, Hinton D, Hu Q et al..  2013.  Methods of Culturing Retinal Pigmented Epithelium Cells, Including Xeno-Free Production, RPE Enrichment, and Cryopreservation.
Hikita S, Clegg DO.  2004.  Osteopontin is Expressed in Developing Mouse Optic Tract and Supports Axon Extension of Retinal Ganglion Cells. Investigative Ophtalmology & Visual Science. 45:5371.
Hikita S, Clegg DO.  2002.  Osteopontin is Expressed in Developing Mouse Retina and Supports Integrin-Dependent Neurite Outgrowth. Investigative Ophtalmology & Visual Science. 43:2698.
Hikita ST, Vistica BP, Jones HR, Keswani JR, Watson MM, Ericson VR, Ayoub GS, Gery I, Clegg DO.  2006.  Osteopontin is proinflammatory in experimental autoimmune uveitis. Investigative Ophthalmology & Visual Science. 47(10):4435-43.
Hikita ST, Kosik KS, Clegg DO, Bamdad C.  2008.  MUC1* mediates the growth of human pluripotent stem cells. PLoS One. 3(10):e3312.
Hikita ST, Cann GM, Wingerd KL, Mullick LH, Wayne WC, Webb SW, Clegg DO.  2003.  Integrin alpha4beta1 (VLA-4) expression and activity in retinal and peripheral neurons. Molecular and Cellular Neuroscience. 23(3):427-39.
Hansma HG, Clegg DO, Kokkoli E, Oroudjev E, Tirrell M.  2002.  Analysis of matrix dynamics by atomic force microscopy. Methods in Cell Biology. 69:163–193.

Pages